An independent pharmacy in Iowa accused CVS Caremark — which accounts for a third of the pharmacy benefit manager market — of forcing local pharmacies to pay direct and indirect remuneration fees.
The DIR fees are an “exploitation” of a loophole that allows PBMs to request money for Medicare Part D prescriptions months or years after they were filled, according to court documents. Caremark and other PBMs allegedly ask for these fees based on performance measures they determine.
“For over half a decade, CVS Caremark has imposed increasing DIR fees on independent pharmacies based on ‘performance criteria’ metrics, many of which make no sense for pharmacies,” the lawsuit, which seeks to be a class-action case, alleges.
A CVS spokesperson told Becker’s the allegations are meritless and the company plans to defend itself.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
